Grant: Planning Grants - Priority Announcement: International Research Collaborations
University of British Columbia
$20,000.00
Narrowing the Gap in the Treatment and Study of Lupus Worldwide
FY 2009-10
Summary
Systemic Lupus Erythematosus (SLE) is the prototypic autoimmune disease. It is a potentially fatal major chronic illness, which disproportionately affects women of childbearing age, persons of colour, Aboriginal peoples and the Chinese. An income disparity across ethnic lines and across countries has led to gaps in the management of SLE around the world. Patients living in the least developed countries of the world share problems with the economically disadvantaged patients living in developed countries. The disparity will increase as new innovative, but very costly, treatments become available. The limited cadre of health providers in the least developed countries and economically disadvantaged regions of developed countries that are knowledgeable about SLE and the rapidly changing therapeutic armamentarium will further increase the gap in patient care.
We propose a special symposium, titled, 'Narrowing the Gap in the Treatment and Study of SLE Worldwide'. This symposium will be the opening session at LUPUS 2010, the 9th International Congress on SLE to be held in Vancouver in June, 2010. A series of workshops will follow-up on the opening symposium and the results will be presented at the closing session.
The symposium and workshops will define the state of art of lupus treatment in settings with constrained resources, build a network of clinicians and scientist to disseminate knowledge, support and build research networks for many autoimmune diseases throughout the world where such networks do not exist. Canada will be the leader in a disease area for which its research is renowned.
Department
Program
Planning Grants - Priority Announcement: International Research Collaborations
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
193394
Name
Esdaile John M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Meetings, Planning and Dissemination Grant: International
Projecttitle
Narrowing the Gap in the Treatment and Study of Lupus Worldwide
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning Grants - Priority Announcement: International Research Collaborations
Keyworddelim
Global Health; Knowledge Dissemination; Knowledge/Collaborative Networks; Systemic Lupus Erythematosus
Abstract
Systemic Lupus Erythematosus (SLE) is the prototypic autoimmune disease. It is a potentially fatal major chronic illness, which disproportionately affects women of childbearing age, persons of colour, Aboriginal peoples and the Chinese. An income disparity across ethnic lines and across countries has led to gaps in the management of SLE around the world. Patients living in the least developed countries of the world share problems with the economically disadvantaged patients living in developed countries. The disparity will increase as new innovative, but very costly, treatments become available. The limited cadre of health providers in the least developed countries and economically disadvantaged regions of developed countries that are knowledgeable about SLE and the rapidly changing therapeutic armamentarium will further increase the gap in patient care.
We propose a special symposium, titled, 'Narrowing the Gap in the Treatment and Study of SLE Worldwide'. This symposium will be the opening session at LUPUS 2010, the 9th International Congress on SLE to be held in Vancouver in June, 2010. A series of workshops will follow-up on the opening symposium and the results will be presented at the closing session.
The symposium and workshops will define the state of art of lupus treatment in settings with constrained resources, build a network of clinicians and scientist to disseminate knowledge, support and build research networks for many autoimmune diseases throughout the world where such networks do not exist. Canada will be the leader in a disease area for which its research is renowned.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Esdaile, John M
Approvedterm
1 an 0 mois
Cihrcontribution2
International Relations~ $10,000~ $0~Knowledge Translation Branch~ $10,000~ $0~